Announcements Trials
Browse Landscape

Phase

Phase 2 41Phase 3 8Phase 1/2 6Phase 1 6Phase NA 5Phase 4 3Phase EARLY_PHASE1 2Phase 2/3 1

Status

Completed 50Recruiting 35Terminated 27Unknown 13Active not recruiting 12Withdrawn 6Not yet recruiting 6

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 6

Conditions

Breast Neoplasms 24Carcinoma, Non-Small-Cell Lung 20Neoplasms 19Colorectal Neoplasms 19Recurrence 17Pancreatic Neoplasms 17Multiple Myeloma 15Advanced Solid Tumors 13Prostatic Neoplasms 12Advanced Solid Tumor 12Stomach Neoplasms 10Ovarian Neoplasms 10Leukemia, Myeloid, Acute 10Carcinoma, Hepatocellular 10Triple Negative Breast Neoplasms 8Neoplasm Metastasis 7Melanoma 7Squamous Cell Carcinoma of Head and Neck 6Small Cell Lung Carcinoma 6Lymphoma, Large B-Cell, Diffuse 6Head and Neck Neoplasms 6Glioblastoma 6Urinary Bladder Neoplasms 5Solid Tumors 5Solid Tumor 5Lymphoma, B-Cell 5Lung Neoplasms 5Liver Neoplasms 5Glioma 5Endometrial Neoplasms 5

Interventions

toripalimab 1osimertinib 1irinotecan sucrosofate 1famitinib 1Platinum Compounds 1Penfluridol 1Pemetrexed 1Paclitaxel 1PM 01183 1Etoposide 1Drug Therapy 1Docetaxel 1Cisplatin 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1/2 × Not yet recruiting × Small Cell Lung Carcinoma × Clear all
NCT07559929 2026-05-29

A Study of DXC006 With Immune Checkpoint Inhibitors or Platinum for Small Cell Lung Cancer.

Hangzhou DAC Biotechnology Co., Ltd.

Phase 1/2 Not yet recruiting
200 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT07472647 2026-03-16

SYS6090 Combination Therapy in Advanced Lung Cancer

Shanghai JMT-Bio Inc.

Phase 1/2 Not yet recruiting
596 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT07414927 2026-02-17

A Clinical Study for the Efficacy and Safety of BL0020 Injection in Patients With Small Cell Lung Cancer Transformed From Non-Small Cell Lung Cancer Following EGFR TKI Therapy

Shanghai Best-Link Bioscience, LLC

Phase 1/2 Not yet recruiting
48 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT07153055 2025-12-18

LOTS

Indiana University

Phase 1/2 Not yet recruiting
16 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT07206563 2025-10-03

Penfluridol for Relapsed/Refractory Small Cell Cancers

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 1/2 Not yet recruiting
33 enrolled
Thoracic

Recurrence, Carcinoma, Small Cell, Small Cell Lung Carcinoma

NCT06332950 2024-03-27

Safety and Efficacy of Adebrelimab Plus Irinotecan Liposome (II) With or Without Famitinib in ES-SCLC Pre-treated With Immunotherapy

Shanghai Chest Hospital

Phase 1/2 Not yet recruiting
80 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡